Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short term Debt (2021 - 2024)

Biodesix (BDSX) has disclosed Short term Debt for 4 consecutive years, with $5.8 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Short term Debt fell 59.91% year-over-year to $5.8 million, compared with a TTM value of $5.8 million through Jun 2024, down 59.91%, and an annual FY2023 reading of $21.9 million, up 111.36% over the prior year.
  • Short term Debt was $5.8 million for Q2 2024 at Biodesix, down from $19.2 million in the prior quarter.
  • Across five years, Short term Debt topped out at $21.9 million in Q4 2023 and bottomed at $5.8 million in Q2 2024.
  • Average Short term Debt over 4 years is $13.7 million, with a median of $13.1 million recorded in 2021.
  • The sharpest move saw Short term Debt surged 111.36% in 2023, then tumbled 59.91% in 2024.
  • Year by year, Short term Debt stood at $17.8 million in 2021, then tumbled by 41.79% to $10.3 million in 2022, then soared by 111.36% to $21.9 million in 2023, then crashed by 73.29% to $5.8 million in 2024.
  • Business Quant data shows Short term Debt for BDSX at $5.8 million in Q2 2024, $19.2 million in Q1 2024, and $21.9 million in Q4 2023.